Your Location:
Home >
Browse articles >
Zuoguiwan Treats Cyclophosphamide-induced Premature Ovarian Failure by Regulating SLC7A11/GPX4 Pathway to Inhibit Ferroptosis
Zuoguiwan Treats Cyclophosphamide-induced Premature Ovarian Failure by Regulating SLC7A11/GPX4 Pathway to Inhibit Ferroptosis
- “The latest research has found that Zuo Gui Wan inhibits ferroptosis and improves ovarian function in premature ovarian failure rats by regulating the SLC7A11/GPX4 pathway.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 17, Pages: 60-66(2024)
DOI: 10.13422/j.cnki.syfjx.20240903
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 3 ) Tabs( 3 )
References
Publication Info
Metrics
503
Views
367
Downloads
4
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Pathogenesis and Treatment of Combined Phlegm and Stasis in Lung Cancer Based on Abnormal Iron Metabolism
Mechanisms and Translational Prospects of Active Components of Traditional Chinese Medicine in Modulating Lipid Metabolism Reprogramming to Induce Ferroptosis in Hepatocellular Carcinoma
Mechanism of Wendan Tang Against Atherosclerosis by Regulating Ferroptosis Based on JAK2/STAT3 Signaling Pathway
Xianglian Huazhuo Prescription Treats Chronic Atrophic Gastritis by Inhibiting Ferroptosis via Regulating lncRNA NOTCH1/miR-138-5p/SIRT1 Axis
Exploring Mechanism of Luoshi Neiyi Prescription in Treating Endometriosis Based on Ferroptosis and Serum Metabolomics
Related Author
YANG Xiaoyu
NING Zixin
LIU Ying
LEI Tong
SHEN Li
YANG Jianfei
LIN Huanhuan
SHI Xiaoli
Related Institution
Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences
School of Clinical Medicine,Gansu University of Chinese Medicine
The First Affiliated Hospital of Gansu University of Chinese Medicine
Jiangxi University of Chinese Medicine
The Affiliated Hospital of Jiangxi University of Chinese Medicine


